Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Antisauvagine-30 TFA (aSvg-30 TFA) is a highly selective and competitive antagonist of CRF2 receptor peptidic. It shows a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 531.00 | |
5 mg | Inquiry | $ 1,586.00 |
Description | Antisauvagine-30 TFA (aSvg-30 TFA) is a highly selective and competitive antagonist of CRF2 receptor peptidic. It shows a Kd of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively. |
Targets&IC50 | CRFR1:150 nM (kd), CRFR2β (mouse):(kd)1.4 nM |
In vitro | Antisauvagine-30 prevents stress-enhanced fear conditioning and Mek-1/2-dependent activation of Erk-1/2 and p90Rsk-1. It did not affect the phosphorylation of the PKA regulatory subunit II of stressed mice [1][2]. |
In vivo | Antisauvagine-30 (i.h. 400 ng/0.5 μl per mouse) selectively prevents the stress-induced enhancement of fear conditioning without affecting the fear conditioning of nonstressed mice[2]. Antisauvagine-30 injected i.c.v. elicits a significant anxiogenic effect [3]. |
Synonyms | Antisauvagine-30 TFA, aSvg-30 TFA |
Molecular Weight | 3764.28 |
Formula | C163H275N48F3O49S |
CAS No. | T10338 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Antisauvagine-30 TFA (220673-95-0 free base) T10338 Others Antisauvagine 30 TFA (220673 95 0 free base) 220673-95-0 free base Antisauvagine-30 TFA 220673-95-0 Antisauvagine30 TFA (220673950 free base) aSvg-30 TFA inhibitor inhibit